Pyrazolopyridines as kinase inhibitors
US8372842B2 · kind B2 · utility
14Cited by
9References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2009 |
| Grant date | Feb 12, 2013 |
| Priority date | — |
| Expiry date | Aug 14, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula I are useful for inhibition of CHK1 and/or CHK2. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.